|
|
Volumn 5, Issue 16, 2013, Pages 1935-1952
|
|
Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE;
ENZYME INHIBITOR;
LYSOPHOSPHATIDIC ACID;
LYSOPHOSPHATIDIC ACID RECEPTOR;
LYSOPHOSPHOLIPID;
PHOSPHODIESTERASE;
PHOSPHONIC ACID DERIVATIVE;
PHOSPHOROUS ACID;
ANIMAL;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG SCREENING;
GENETICS;
LUNG FIBROSIS;
METABOLISM;
MOLECULAR LIBRARY;
REVIEW;
ANIMALS;
DRUG EVALUATION, PRECLINICAL;
ENZYME INHIBITORS;
LYSOPHOSPHOLIPIDS;
PHOSPHORIC DIESTER HYDROLASES;
PHOSPHOROUS ACIDS;
PULMONARY FIBROSIS;
RECEPTORS, LYSOPHOSPHATIDIC ACID;
SMALL MOLECULE LIBRARIES;
|
|
EID: 84891325803
PISSN: None
EISSN: 17568927
Source Type: Journal
DOI: 10.4155/fmc.13.154 Document Type: Review |
|
Times cited : (31)
|
|
References (0)
|
